Japan’s Astellas Pharma to buy Iveric Bio in deal worth $5.9 billion
Astellas Pharma Inc. said Monday that it agreed to acquire Iveric bio Inc. for about $5.9 billion to strengthen its ...
Read moreTag: JP:4503
- Trending
- Comments
- Latest
Astellas Pharma Inc. said Monday that it agreed to acquire Iveric bio Inc. for about $5.9 billion to strengthen its ...
Read more
